Curis, Inc. (CRIS)
0.5171
+0.02
(+4.63%)
USD |
NASDAQ |
May 27, 14:57
Curis Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -154.64M |
| Kura Oncology, Inc. | -24.23M |
| Agenus, Inc. | 68.95M |
| Plus Therapeutics, Inc. | -8.533M |
| Windtree Therapeutics, Inc. | -0.789M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.001M |
| Cash from Financing (Quarterly) | 18.94M |
| Free Cash Flow | -28.95M |
| Free Cash Flow Per Share (Quarterly) | -0.4648 |
| Free Cash Flow to Equity (Quarterly) | -8.72M |
| Free Cash Flow to Firm (Quarterly) | -9.001M |
| Free Cash Flow Yield | -353.1% |